TY  - JOUR
T1  - An Experiential Analysis of the SARS Cov-2 Infection Stages and Therapeutics from a COVID-19 Survivor
A1  - Josphert Ngui. Kimatu
A1  - Patriciah Kalunde. King'esi
JF  - International Journal of Pharmaceutical And Phytopharmacological Research
JO  - Int J Pharm Phytopharmacol Res
SN  - 2250-1029
Y1  - 2021
VL  - 11
IS  - 2
DO  - 10.51847/6eRs6Z3kWb
SP  - 74
EP  - 79
N2  - In late 2019, there was an emergence of a SARS-CoV-2 strain of the coronavirus with the first reports coming from Wuhan China. This strain has since spread and mutated across the world causing a pandemic as of June 2021. The SARS-CoV-2 causes a disease called COVID-19 in the human body. The progression of the disease symptoms has not been systematically illustrated fully. This paper attempts to logically give a scientific guide on the progressive development of the symptoms experienced by most COVID-19 patients. The study is based on a personal infection of SARS CoV-2, symptom evaluation, medication, and recovery from COVID-19. It also looks comparatively at other literature and patients’ experiences. The patient data was collected during the second SARS-CoV-2 wave in Kenya with reports of the South Africa SARS CoV-2 strain being reported in the country. The study recommends a continuous pathogenies evaluation of the subsequent SAR CoV-2 variants infection pathways. This shall decipher the main attack models of the new variants and thereafter in the development and validation of COVID-19 vaccines. 
UR  - https://eijppr.com/article/an-experiential-analysis-of-the-sars-cov-2-infection-stages-and-therapeutics-from-a-covid-19-survivo-tazzdffuggakijb
ER  -